Literature DB >> 17060675

Determination of binding specificities in highly multiplexed bead-based assays for antibody proteomics.

Jochen M Schwenk1, Johan Lindberg, Mårten Sundberg, Mathias Uhlén, Peter Nilsson.   

Abstract

One of the major challenges of antibody-based proteomics is the quality assurance of the generated antibodies to ensure specificity to the target protein. Here we describe a single tube multiplex approach to simultaneously analyze the binding of antibodies to a large number of different antigens. This bead-based assay utilizes the full multiplexing capacity theoretically offered by the Luminex suspension array technology. A protocol for an increased coupling throughput for the immobilization of antigens was developed and used to set up complex and stabile 100-plex bead mixtures. The possibility of using a two-dimensional multiplexing, in terms of high numbers of both analytes and samples or as in this case antigens and antibodies, enables the specificity of 96 antibodies versus 100 different antigens to be determined in 2 h. This high throughput analysis will potentially have great impact on the possibility for the utilization of different antibody proteomics approaches where the quality assessment of antibodies is of the utmost importance.

Mesh:

Substances:

Year:  2006        PMID: 17060675     DOI: 10.1074/mcp.T600035-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  24 in total

Review 1.  Cell-based screening using high-throughput flow cytometry.

Authors:  Christopher B Black; Thomas D Duensing; Linda S Trinkle; R Terry Dunlay
Journal:  Assay Drug Dev Technol       Date:  2010-11-04       Impact factor: 1.738

2.  Lysate microarrays enable high-throughput, quantitative investigations of cellular signaling.

Authors:  Mark Sevecka; Alejandro Wolf-Yadlin; Gavin MacBeath
Journal:  Mol Cell Proteomics       Date:  2011-02-04       Impact factor: 5.911

3.  Toward next generation plasma profiling via heat-induced epitope retrieval and array-based assays.

Authors:  Jochen M Schwenk; Ulrika Igel; Maja Neiman; Hanno Langen; Charlotte Becker; Anders Bjartell; Fredrik Ponten; Fredrik Wiklund; Henrik Grönberg; Peter Nilsson; Mathias Uhlen
Journal:  Mol Cell Proteomics       Date:  2010-08-03       Impact factor: 5.911

4.  Development of a coordinated allo T cell and auto B cell response against autosomal PTK2B after allogeneic hematopoietic stem cell transplantation.

Authors:  Anita N Kremer; Judith C van der Griendt; Edith D van der Meijden; M Willy Honders; Burcu Ayoglu; Jochen M Schwenk; Peter Nilsson; J H Frederik Falkenburg; Marieke Griffioen
Journal:  Haematologica       Date:  2013-10-04       Impact factor: 9.941

Review 5.  Antibody-based protein multiplex platforms: technical and operational challenges.

Authors:  Allison A Ellington; Iftikhar J Kullo; Kent R Bailey; George G Klee
Journal:  Clin Chem       Date:  2009-12-03       Impact factor: 8.327

6.  Profiling lipid-protein interactions using nonquenched fluorescent liposomal nanovesicles and proteome microarrays.

Authors:  Kuan-Yi Lu; Sheng-Ce Tao; Tzu-Ching Yang; Yu-Hsuan Ho; Chia-Hsien Lee; Chen-Ching Lin; Hsueh-Fen Juan; Hsuan-Cheng Huang; Chin-Yu Yang; Ming-Shuo Chen; Yu-Yi Lin; Jin-Ying Lu; Heng Zhu; Chien-Sheng Chen
Journal:  Mol Cell Proteomics       Date:  2012-07-26       Impact factor: 5.911

7.  µFBI: a microfluidic bead-based immunoassay for multiplexed detection of proteins from a µL sample volume.

Authors:  Xiaobo Yu; Michael Hartmann; Quan Wang; Oliver Poetz; Nicole Schneiderhan-Marra; Dieter Stoll; Cornelia Kazmaier; Thomas O Joos
Journal:  PLoS One       Date:  2010-10-01       Impact factor: 3.240

8.  Recombinant surface proteomics as a tool to analyze humoral immune responses in bovines infected by Mycoplasma mycoides subsp. mycoides small colony type.

Authors:  Carl Hamsten; Maja Neiman; Jochen M Schwenk; Marica Hamsten; John B March; Anja Persson
Journal:  Mol Cell Proteomics       Date:  2009-08-20       Impact factor: 5.911

9.  Increased expression of the frontotemporal dementia risk factor TMEM106B causes C9orf72-dependent alterations in lysosomes.

Authors:  Johanna I Busch; Travis L Unger; Nimansha Jain; R Tyler Skrinak; Rakshita A Charan; Alice S Chen-Plotkin
Journal:  Hum Mol Genet       Date:  2016-04-28       Impact factor: 6.150

10.  Discovery of epitopes for targeting the human epidermal growth factor receptor 2 (HER2) with antibodies.

Authors:  Johan Rockberg; Jochen M Schwenk; Mathias Uhlén
Journal:  Mol Oncol       Date:  2009-01-31       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.